Superior Bioavailability
Oral bioavailability is predicted to be 80% based on a model of intestinal absorption and metabolism, more than double that of oral or intranasal absorption of ketamine, promising a potential shift to observed oral, home administration, granting patients greater autonomy, convenience, and accessibility to a potentially effective depression treatment
InSilico Analysis
